Wockhardt Limited
WOCKPHARMA
株式のランク
#4524
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
株価
$21.04
最終同期: 2026-10-19
時価総額
$3.42B
変化（1日）
-2.39%
変化（1年）
34.90%
国
IN
取引 Wockhardt Limited (WOCKPHARMA)
カテゴリー
Healthcare
Wockhardt Limited（WOCKPHARMA）のP/B比率
October 2026 時点のP/B比率 TTM: 6.02
Wockhardt Limited の最新の財務報告および株価によると、現在のP/B比率（TTM）は 6.02 です。2024 年末時点でのP/B比率は 2.57 でした。
Wockhardt Limited の P/B 比率の履歴（2004 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 6.02 | 16.16% |
| 2025 | 5.18 | 101.34% |
| 2024 | 2.57 | 288.97% |
| 2023 | 0.66 | -19.95% |
| 2022 | 0.83 | -43.97% |
| 2021 | 1.47 | 89.81% |
| 2020 | 0.78 | -61.99% |
| 2019 | 2.04 | -35.21% |
| 2018 | 3.15 | 21.94% |
| 2017 | 2.59 | -14.18% |
| 2016 | 3.01 | -49.76% |
| 2015 | 6.00 | 294.23% |
| 2014 | 1.52 | -82.90% |
| 2013 | 8.90 | 84.07% |
| 2012 | 4.83 | 41.70% |
| 2011 | 3.41 | 72.95% |
| 2010 | 1.97 | 55.55% |
| 2008 | 1.27 | -67.48% |
| 2007 | 3.90 | -0.89% |
| 2006 | 3.93 | -39.11% |
| 2005 | 6.46 | -5.15% |
| 2004 | 6.81 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 3.8424 | -36.14% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 17.3539 | 188.42% |
US
|
